InsidersTradesSigma
Discover the full management transaction log of Bluejay Diagnostics, Inc., a listed issuer based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). Operating in the Healthcare sector, Bluejay Diagnostics, Inc. has published 6 reports. Market capitalisation: €1.8m. The latest transaction was filed on 27 April 2022 — Acquisition. Among the most active insiders: Kinder Gordon Winston. The full history is openly available.
FY ended December 2025 · cache
0 of 0 declarations